3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Prostatic Neoplasms
5
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Hepatoblastoma
1
Cardiovascular Diseases
1
Carcinoma, Renal Cell
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Filgrastim
6
Cyclophosphamide
6
Carboplatin
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Ifosfamide
5
Temozolomide
4
Nuclear Medicine Department, Hospital
4
Gemcitabine
4
Etoposide
4
Granulocyte Colony-Stimulating Factor
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ixabepilone
2
ivosidenib
2
etoposide phosphate
2
ensartinib
2
cabozantinib
2
belinostat
2
Vincristine
2
Vemurafenib
2
Topotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Simvastatin
×
Genitourinary
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled